Healthcare provider profile · identity verified

Latosha Larkin Corley

Nurse Practitioner · ORANGEBURG, SC · NPI 1376193383

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	382	106
Atorvastatin Calcium	Atorvastatin Calcium	292	85
Levothyroxine Sodium	Levothyroxine Sodium	178	45
Metformin Hcl	Metformin Hcl	138	40
Omeprazole	Omeprazole	123	35
Losartan Potassium	Losartan Potassium	119	40
Fluconazole	Fluconazole	118	84
Mounjaro	Tirzepatide	111	23
Gabapentin	Gabapentin	96	33
Rosuvastatin Calcium	Rosuvastatin Calcium	85	34
Hydrochlorothiazide	Hydrochlorothiazide	84	26
Metoprolol Succinate	Metoprolol Succinate	84	30
Alprazolam	Alprazolam	77	21
Potassium Chloride	Potassium Chloride	76	22
Furosemide	Furosemide	74	31
Zolpidem Tartrate	Zolpidem Tartrate	70	12
Fluticasone Propionate	Fluticasone Propionate	57	24
Lisinopril	Lisinopril	57	12
Tramadol Hcl	Tramadol Hcl	56	20
Pantoprazole Sodium	Pantoprazole Sodium	54	20
Clonidine Hcl	Clonidine Hcl	52	11
Montelukast Sodium	Montelukast Sodium	52	15
Simvastatin	Simvastatin	50	12
Eliquis	Apixaban	47	13
Albuterol Sulfate Hfa	Albuterol Sulfate	46	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	20
Metoprolol Tartrate	Metoprolol Tartrate	45	13
Carvedilol	Carvedilol	44	17
Mirtazapine	Mirtazapine	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	17
Tamsulosin Hcl	Tamsulosin Hcl	43	16
Meclizine Hcl	Meclizine Hcl	39	12
Azithromycin	Azithromycin	38	35
Valsartan	Valsartan	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	11
Kerendia	Finerenone	32	suppressed
Edarbyclor	Azilsartan Med/Chlorthalidone	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Famotidine	Famotidine	29	16
Nifedipine Er	Nifedipine	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	14
Trulicity	Dulaglutide	29	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	11
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Ezetimibe	Ezetimibe	27	11
Risperidone	Risperidone	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	25
Donepezil Hcl	Donepezil Hcl	26	suppressed
Ozempic	Semaglutide	26	suppressed
Finasteride	Finasteride	25	suppressed
Glipizide	Glipizide	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Spironolactone	Spironolactone	24	suppressed
Allopurinol	Allopurinol	23	13
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Trazodone Hcl	Trazodone Hcl	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	11
Jardiance	Empagliflozin	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Irbesartan	Irbesartan	21	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	20	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Colchicine	Colchicine	18	11
Farxiga	Dapagliflozin Propanediol	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Prednisone	Prednisone	14	12
Synthroid	Levothyroxine Sodium	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Estradiol	Estradiol	13	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Methimazole	Methimazole	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Sertraline Hcl	Sertraline Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Atenolol	Atenolol	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Ofloxacin	Ofloxacin	11	suppressed
Olanzapine-Fluoxetine Hcl	Olanzapine/Fluoxetine Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Single Use Swab	Alcohol Antiseptic Pads	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error